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Abstract
Purpose:  To  evaluate  preliminarily  the  safety  and  efﬁcacy  of  customized  photorefractive  ker-
atectomy (PRK)  to  correct  ametropia  and  irregular  astigmatism  after  penetrating  keratoplasty
(PK).
Methods: This  pilot  study  included  ﬁve  eyes  of  ﬁve  patients  with  a  mean  spherical  equivalent  of
−5.1 ±  1.46  D  (range  from  −2.75  to  −6.50  D).  In  all  cases,  ametropia  and  irregular  astigmatism
was corrected  with  topography-guided  customized  PRK.  Ocular  examinations  with  topographic
analysis were  performed  preoperatively  as  well  as  at  1,  3  and  6  months  after  surgery.
Results:  All  eyes  gained  postoperatively  at  least  three  Snellen  lines  of  uncorrected  visual  acuity.
Mean refractive  spherical  equivalent  was  0.62  ±  0.63  D  (range  from  −0.25  to  −1.75  D)  at  6
months postoperatively.
Conclusion:  Our  pilot  study  suggests  that  customized  PRK  can  be  a  safe  and  effective  method
for treating  ametropia  and  irregular  astigmatisms  after  PK.  Future  studies  with  larger  samples
and longer  follow-ups  should  be  performed  to  conﬁrm  these  results.
© 2013  Spanish  General  Council  of  Optometry.  Published  by  Elsevier  España,  S.L.U.  All  rights
reserved.∗ Corresponding author.
E-mail address: g.derosaoftalmologia@libero.it (G. De Rosa).
888-4296/$ – see front matter © 2013 Spanish General Council of Optometry. Published by Elsevier España, S.L.U. All rights reserved.
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Queratectomía  fotorrefractiva  personalizada  para  corregir  altas  ametropías  tras
queratoplastia  penetrante:  estudio  piloto
Resumen
Objetivo:  Evaluar  preliminarmente  la  seguridad  y  eﬁcacia  de  la  queratectomía  fotorrefractiva
personalizada  (PRK)  para  corregir  la  ametropía  y  astigmatismo  irregular  tras  queratoplastia
penetrante  (PK).
Métodos:  Este  estudio  piloto  incluía  un  total  de  5  ojos  de  5  pacientes  con  un  equivalente  esférico
medio de  −5,1  ±  1,46  D  (rango  entre  −2,75  y  −6,50  D).  En  todos  los  casos,  la  ametropía  y  astig-
matismo irregular  se  corrigió  mediante  PRK  personalizada  guiada  por  topografía.  Se  realizaron
exámenes  oculares  con  análisis  topográﬁco  preoperatoriamente,  así  como  a  los  1,  3  y  6  meses
tras la  cirugía.
Resultados:  Todos  los  ojos  ganaron  al  menos  3  líneas  de  agudeza  visual  Snellen  no  corregida.
El equivalente  esférico  medio  fue  de  0,62  ±  0,63  D  (rango  entre  −0,25  y  −1.75  D)  a  los  6  meses
tras la  cirugía.
Conclusión:  Nuestro  estudio  piloto  sugiere  que  la  PRK  personalizada  puede  ser  un  método  seguro
y eﬁcaz  para  el  tratamiento  de  la  ametropía  y  el  astigmatismo  irregular  tras  PK.  Deben  realizarse
futuros estudios  con  muestras  de  pacientes  mayores  y  seguimientos  más  largos  que  conﬁrmen
estos resultados.
©  2013  Spanish  General  Council  of  Optometry.  Publicado  por  Elsevier  España,  S.L.U.  Todos  los
derechos reservados.
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Keratoconus  (KC)  is  characterized  by  progressive  corneal
protrusion  and  thinning,  leading  to  irregular  astigmatism
and  impairment  of  visual  function.  KC  is  among  the  best
indications  for  doing  a  penetrating  keratoplasty  (PKP),  with
long-term  graft  survival  rates  surpassing  those  for  any  other
indication.1,2 Generally  accepted  indications  for  PKP  in  KC
are  poor  visual  acuity  with  contact  lenses,  contact  lens
intolerance  or  inability  to  ﬁt/wear  contact  lenses,  and
non-resolving  corneal  hydrops.  The  percentage  of  patients
with  KC  eventually  requiring  PKP  varies  widely  in  dif-
ferent  reports.3--7 Residual  refractive  error  and  corneal
irregularity  following  PKP  can  be  managed  with  spectacles
or  contact  lenses.  However,  although  advances  in  techniques
and  instrumentations  for  PKP,  especially  the  introduction
of  femtosecond  lasers,  have  greatly  improved  PKP  results,
high  refractive  errors,  especially  high  astigmatisms,  asso-
ciated  to  high  levels  of  corneal  irregularity,  may  appear
postoperatively  in  spite  of  an  uneventful  surgical  proce-
dure.  These  optical  errors  are  hardly  correctable  and  very
disturbing  for  the  patient.8--10 In  order  to  reduce  residual
astigmatism  after  PKP,  some  options  have  been  described:
surgical  approaches  such  as  relaxing  incisions,11,12 wedge
resection  as  well  as  selective  removal  of  sutures,  which  is  a
less  predictable  and  stable  method.13--16 Some  of  the  most
common  related  complications  to  this  last  method  are  the
risk  for  wound  dehiscence,  transplant  rejection,  and  unsolv-
able  topographic  and  refractive  ﬂuctuations.17 Crystalline
lens  extraction  with  IOL  implantation  can  correct  ametropia
but  not  corneal  aberrations  and  some  risks  are  associated  to
this  procedures,  such  as  endophthalmitis,  secondary  glau-
coma,  retinal  detachment,  or  endothelial  cell  loss.18--20
The  use  of  the  excimer  laser  is  a  safe  and  effective
technique  to  correct  post-keratoplasty  ametropia.21--24 How-
A
l
n
aver,  conventional  LASIK  and  PRK  have  limitations  because
hey  are  unable  to  correct  the  irregularity  of  the  post-
ransplantation  corneal  surface.  Furthermore,  some  risks  of
he  LASIK  technique  due  to  the  creation  of  the  ﬂap  should
e  considered,  such  as  the  creation  of  incomplete,  irregular
r  even  damaged  ﬂaps.25--27 PRK  is  a  safe  and  reliable  tech-
ique  but  the  risks  of  corneal  haze  and  refractive  regression
hould  be  also  considered.28--31
Customized  topography-guided  corneal  ablation  with
xcimer  laser  is  a  procedure  that  can  be  used  to  correct
ot  only  ametropia  after  penetrating  keratoplasty  (PKP),  but
lso  irregular  astigmatisms.32 We  have  used  this  technique  to
reat  ametropia  and  irregular  astigmatism  after  PKP  in  ﬁve
f  our  patients  in  the  attempt  of  verifying  its  efﬁcacy,  pre-
ictability,  and  safety.  Therefore,  the  purpose  of  the  current
tudy  was  to  evaluate  preliminarily  the  safety  and  efﬁcacy
f  topography-guided  customized  PRK  for  the  correction  of
rregular  astigmatism  after  PKP.
ethods
his  study  comprised  of  ﬁve  eyes  of  ﬁve  patients  with
igniﬁcant  residual  ametropia  (mean  spherical  equivalent
5.1  ±  1.46  D,  range  −2.75  D  to  −6.50  D)  and  irregular  astig-
atism  after  PKP  that  was  treated  by  customized  PRK.
atient  age  ranged  from  49  years  to  61  years.  The  sample
ncluded  one  male  and  four  female  patients.
All  patients  had  undergone  PKP  at  least  18  months  before
RK,  with  removal  of  sutures  at  least  6  months  before  PRK.
n  all  cases,  PKP  has  been  performed  due  to  the  presence
f  keratoconus  of  grade  3  or  4  according  to  the
msler--Krumeich  classiﬁcation.  After  suture  removal,  no
arge  changes  in  manifest  refraction  were  observed.  As  a  sig-
iﬁcant  ametropia  was  present  in  the  eye  with  previous  PKP,
 signiﬁcant  level  of  aniseikonia  was  present  in  all  patients,
176  G.  De  Rosa  et  al.
1
0
–1
–2
–3
–4
–5
–6
–7
Before surgery 3 months
Mean and standard deviation of spherical equivalent
6 months 12 months
F
f
n
c
s
c
n
T
t
t
1
t
d
a
I
c
t
a
K
t
e
i
a
d
t
r
t
t
I
d
t
d
p
o
t
w
0
e
b
c
d
1 
Re
fr
ac
ti
ve
 
da
ta
 
of
 
ea
ch
 
pa
ti
en
t 
pr
eo
pe
ra
ti
ve
ly
 
an
d 
po
st
op
er
at
iv
el
y.
Pa
ti
en
t 
ag
e/
se
x/
ey
e
Pr
e-
op
3 
m
on
th
s
6 
m
on
th
s
12
 
m
on
th
s
54
/F
/l
ef
t 
sf
 
− 
4.
00
 
= 
cy
l −
 
3.
00
 
× 
14
0◦
cy
l 
− 
1.
00
 
× 
13
5◦
sf
 
+ 
0.
25
 
= 
cy
l −
 
1.
00
 
× 
14
0◦
sf
 
+ 
0.
25
 
= 
cy
l −
 
1.
00
 
× 
14
0◦
58
/F
/r
ig
ht
 
sf
 
− 
1.
50
 
= 
cy
l −
 
9.
00
 
× 
65
◦
cy
l −
 
3.
00
 
× 
60
◦
sf
 
− 
0.
50
 
= 
cy
l −
 
2.
50
 
× 
55
◦
sf
 
− 
0.
50
 
= 
cy
l −
 
1.
50
 
× 
50
◦
49
/F
/r
ig
ht
 
sf
 
− 
1.
00
 
= 
cy
l −
 
3.
50
 
× 
5◦
sf
 
+ 
0.
25
 
= 
cy
l −
 
0.
75
 
× 
5◦
cy
l −
 
0.
50
 
× 
10
◦
cy
l −
 
0.
50
 
× 
10
◦
61
/F
/r
ig
ht
 
sf
 
− 
3.
00
 
= 
cy
l −
 
3.
50
 
× 
16
0◦
sf
 
+ 
0.
50
 
= 
cy
l −
 
1.
00
 
× 
16
0◦
sf
 
+ 
0.
25
 
= 
cy
l −
 
0.
75
 
× 
15
5◦
sf
 
− 
0.
50
 
= 
cy
l −
 
0.
50
 
× 
16
0◦
51
/M
/r
ig
ht
 
sf
 
− 
4.
00
 
= 
cy
l −
 
5.
00
 
× 
10
◦
sf
 
+ 
0.
50
 
= 
cy
l −
 
1.
25
 
× 
10
◦
sf
 
+ 
0.
25
 
= 
cy
l −
 
1.
00
 
× 
10
◦
sf
 
+ 
0.
25
 
= 
cy
l −
 
1.
25
 
× 
10
◦igure  1  Mean  spherical  equivalent  in  diopters  (D)  during  the
ollow-up.
ot  allowing  them  the  use  of  spectacles.  Furthermore,  in  all
ases,  the  refraction  was  stable  for  at  least  6  months  after
uture  removal.  All  eyes  from  the  sample  were  intolerant  to
ontact  lenses.
An informed  consent  about  the  risks,  beneﬁts,  and  alter-
ative  treatment  methods  was  signed  by  all  the  patients.
his  study  received  approval  of  the  Ethics  Committee  of
he  hospital  where  the  study  was  conducted,  following  the
enets  of  the  Helsinki  Declaration.
Preoperatively  and  in  each  postoperative  visit  (3,  6,  and
2  months  after  surgery),  a  complete  ophthalmic  examina-
ion  was  performed  in  all  patients  including:  uncorrected
istance  visual  acuity  (UDVA),  corrected  distance  visual
cuity  (CDVA),  corneal  topography  (Keratron,  Optikon  2000
nc.),  corneal  aberrometry  (VISX  WaveScan  AMO  Inc.),  opti-
al  pachymetry  (Oculus  Pentacam  HR,  Oculus),  air-puff
onometry  (TonoRef  II  RKT-7700,  Nidek)  and  endothelial  cell
nalysis  with  a  specular  microscope  (NonconRobo  Sp-8000,
onan).
For  the  treatment,  an  acquisition  of  two  very  similar
opography  maps  was  performed,  with  a  maximum  differ-
nce  of  3  micrometers  between  all  the  processed  points
n  the  5  mm  central  zone  of  the  cornea.  This  process  was
imed  at  ensuring  the  obtainance  of  reliable  corneal  surface
ata.  The  elevation  data  obtained  with  the  topographer,
he  patient’s  manifest  refraction  as  well  as  the  aberromet-
ic  data  were  uploaded  to  the  software  of  calculation  of
he  ablation  proﬁle.  The  customized  ablation  proﬁle  was
hen  transferred  to  the  excimer  laser  VISX  Star  S4  IR  (AMO
nc.)  computer.  Only  corneal  aberrometric  data  were  used  to
esign  the  laser  ablation  proﬁle.  The  procedure  was  planned
o  achieve  the  correction  of  the  spherocylindrical  refractive
efect  and  the  minimization  of  corneal  HOAs.  The  ablation
roﬁle  obtained  was  transferred  to  the  laser  computer  for
ptimal  positioning  of  the  laser  beam.
In  each  eye,  one  drop  of  4%  lidocaine  was  instilled  4
imes  every  5  min  before  treatment.  The  non-treated  eye
as  occluded  during  surgery,  whereas  antibiotic  drops  of
.3%  netilmicin  (Nettacin)  were  instilled  in  the  affected
ye.  After  epithelium  removal  with  an  Amoils  rotating
rush,  the  customized  laser  procedure  was  performed.  To
enter  the  treatment,  patient’s  pupil  was  automatically
etected  by  the  excimer  laser  and  topographic  and  refrac-
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PRK  after  PKP  
Table  2  Corrected  distance  visual  acuity  during  the  follow-
up.
Patient  Pre-op  3  months  6  months  12  months
1  20/25  20/25  20/20  20/20
2 20/63  20/40  20/32  20/32
3 20/25  20/25  20/20  20/20
a
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S4 20/32  20/25  20/20  20/20
5 20/32  20/32  20/25  20/25
tive  data  were  utilized.  We  did  not  use  the  transepithelial
technique  because  of  the  corneal  anomalies  and  irregulari-
ties  that  are  usually  present  in  post-PKP  corneas,  and  also
considering  that  there  are  some  papers  stating  the  effec-
tiveness  of  the  surgical  procedure  used.7,15,16 One  drop  of
netilmicin  0.3%  (Nettacin),  ﬂuorometholone  0.1%  (Fluaton)
eye  drops  and  a  contact  lens  (Protek  T&S,  Contact  Vision)
were  applied  postoperatively.  The  postoperative  treatment
included  netilmicin  0.3%  eye  drops  4  times  daily  for  1  month,
clobetasone  (Visucloben)  eye  drops  4  times  a  day  for  1  week
and  then  reducing  during  the  next  3  weeks  and  hyaluronic
acid  0.2%  (Hyalistil  eye  drops  4  times  daily  for  3  months,
then  3  times  a  day  for  the  next  3  months).
Results
The  preoperative  and  postoperative  patients’  data  are
shown  in  Table  1.  All  eyes  had  an  UDVA  equal  to  or  bet-
ter  than  20/400  (1.1  LogMAR)  preoperatively.  The  treatment
resulted  in  an  improvement  of  UDVA  that  remained  sta-
ble  throughout  the  follow-up.  After  treatment,  two  eyes
y
i
a
Table  3  Mean  value  ±  standard  deviation  of  pachymetry,  intraoc
distance visual  acuity  (CDVA),  sphere  in  diopters  (Sph),  cylindrical
(SE) during  the  follow-up.
Pre-op  3  months  
Pachymetry  (m)  (SD)  531.8  (17.5)  427.6  (12.8)  
IOP (mmHg)  (SD)  16  (0.70)  12  (1.58)  
ECD (cell/mm2)  2162.2  (156.64)  2146.2  (149.77)  
LogMAR CDVA  0.22  (0.16)  0.16  (0.09)  
LogMAR UDVA  1.08  (0.04)  0.58  (0.16)  
Sph (D)  −2.70  (1.39)  0.25  (0.25)  
Cyl (D)  −4.80  (2.46)  −1.40  (0.91)  
SE (D)  −5.1  (1.4)  −0.44  (0.61)  
Table  4  Difference  between  preoperative  and  after  12  months  a
Pre-op  (mean  ±  SD)  12  months  (mean  ±  SD)  
Spherical
aberration
(m)
0.0856  ±  0.11  0.0748  ±  0.27  
Coma (m)  0.264  ±  0.15  0.208  ±  0.12  
Total RMS  (m)  3.528  ±  1.77  1.724  ±  0.86  
SfAb, spherical aberration; Coma, coma aberration; RMS, root mean sq177
chieved  20/50  (0.4  LogMAR)  of  UDVA  and  three  eyes  20/100
0.7  LogMAR),  with  a  gain  of  three  Snellen  lines.
Mean  preoperative  SE  was  −5.1  ±  1.46  D  (range  −2.75  to
6.5  D),  whereas  at  the  last  postoperative  visit  mean  SE
as  −0.62  ±  0.63  D  (range  −0.25  to  −1.75  D).  Fig.  1  shows
hanges  in  mean  SE  during  the  entire  follow-up.  No  patient
ost  lines  of  CDVA.  A  total  of  three  patients  gained  two  lines
f  CDVA,  one  patient  gained  three  lines  and  another  gained
our  lines.  The  visual  outcomes  remained  stable  at  the  last
ollow-up  visit.  Re-epithelization  was  observed  in  all  cases
n  a  period  between  72  and  96  h  after  PRK.
At  the  12-month  postoperative  examination,  three
atients  achieved  20/20  (0.0  LogMAR)  CDVA  (Table  2).  No
atient  needed  secondary  surgery.  No  patients  had  evi-
ent  corneal  haze,  although  two  patients  reported  halos.
ome  subjective  symptoms  such  as  ocular  discomfort,
urning  or  slight  pain  was  easily  resolved  after  steroid
herapy.
Table  3  shows  the  results  obtained  in  the  measure-
ent  of  central  corneal  thickness,  intraocular  pressure
nd  endothelial  cell  count.  Corneal  thickness  was  reduced
n  average  108  m  with  the  laser  ablation,  remaining
n  all  cases  more  than  400  m  of  residual  cornea.  Mean
ntraocular  pressure  values  were  similar  during  the  postop-
rative  follow-up  without  statistically  signiﬁcant  differences
p  =  0.09,  paired  Student’s  t-test).  Mean  endothelial  cell
ensity  did  not  change  signiﬁcantly  between  the  preopera-
ive  and  the  12-month  postoperative  visits  (p  =  0.13,  paired
tudent’s  t-test),  with  a  cell  loss  of  less  than  2%  at  one
ear.
We  did  not  observe  a  statistical  signiﬁcant  change
n  spherical  aberration  (SphA)  and  coma  at  12  months
fter  surgery  (Table  4).  In  addition,  aberrometry  showed  a
ular  pressure  (IOP),  endothelial  cell  density  (ECD),  corrected
 value  in  diopters  (Cyl),  and  spherical  equivalent  in  diopters
6  months  12  months  p  value  (preop  vs.
12  month  postop)
427.8  (12.5)  423.4  (16.2)  <0.05
11.4  (0.89)  11.2  (0.83)  <0.05
2143  (146.57)  2126.2  (138.65)  0.13
0.06  (0.09)  0.06  (0.09)  <0.05
0.58  (0.16)  0.58  (0.16)  <0.05
0.05  (0.32)  −0.05  (0.32)  <0.05
−1.15  (0.78)  −0.95  (0.45)  <0.05
−0.52  (0.68)  −0.62  (0.63)  <0.05
fter  surgery  of  Corneal  Wavefront  Aberrometry.
Mean  difference  ±  SD  Range  p  value
−0.0034  ±  0.199089  From  0.203  to  −0.319  0.971368
0.0556  ±  0.202758  From  0.385  to  −0.127  0.572913
1.8438  ±  1.210581  From  3.342  to  0.086  <0.05
uare; SD, standard deviation.
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sFigure  2  Corneal  topography  preoperative
eduction  of  total  aberrations  root  mean  square  (RMS).
ndeed,  a  statistically  signiﬁcant  difference  in  total  RMS  was
ound  one  year  after  treatment  (p  =  0.027,  paired  Student’s
-test).  Fig.  2 shows  an  example  of  preoperative  and  postop-
rative  corneal  topographies  in  one  case  from  the  sample.
iscussion
ustomized  transepithelial  photorefractive  keratectomy
PRK)  has  been  shown  to  be  effective  in  reducing  post-
eratoplasty  ametropia.33 In  our  series,  a  mean  correction
f  SE  of  87.9%  (range  79--94.3%)  was  found,  with  a strong
mprovement  in  UDVA.  No  patient  lost  any  Snellen  line  of
DVA  or  CDVA.  Therefore,  the  visual  acuity  improved  in  all
atients  with  no  regression  during  a  period  of  12  months
ostoperatively.  As  a  consequence  of  the  laser  treatment,
ll  patients  could  use  spectacle  correction  after  surgery,  as
 high  reduction  of  ametropia  was  achieved.
Also  CDVA  was  beneﬁted  from  the  laser  treatment,
mproving  on  average  three  Snellen  lines,  even  reaching
0/20  in  three  patients.  The  absence  of  haze  and  the  negli-
ible  loss  of  endothelial  cells  demonstrated  the  safety  and
tability  of  the  treatment.  Also,  although  a  reduction  in  total
MS  was  observed,  coma  and  spherical  aberration  were  not
tatistically  reduced.  This  reduction  in  total  corneal  aber-
ations  was  the  consequence  of  a  change  in  some  other
OAs  induced  by  the  excimer  laser.  It  should  be  also  noted
hat  the  small  number  of  our  series  is  a  clear  limitation  for
chieving  statistical  signiﬁcance.  The  customized  ablation
llowed  us  to  obtain  a  corneal  surface  much  more  uniform
han  preoperatively.  Using  the  laser  spot  technology,  with
C
Teft)  and  postoperatively  (right)  (patient  3).
ariable  diameter  and  modulated  frequency,  local  irregu-
arities  can  be  corrected  with  saving  of  corneal  tissue.34
his  saving  of  corneal  tissue  allows  treatment  of  high  levels
f  irregular  astigmatism,  inducing  simultaneously  a  regu-
ar  and  smooth  surface.  The  topo-aberrometric  information
ransmitted  to  the  excimer  laser  allows  a  precise  treatment
lanning  that  combined  with  a  highly  precise  alignment
nd  an  accurate  centering  lead  to  excellent  levels  of  visual
ehabilitation.  Visual  acuity  improvement  is  related  to  the
egularization  of  the  corneal  surface  and  the  enhancement
f  topographic  parameters.  The  reduction  of  the  total  aber-
ations  lead  to  an  improvement  in  the  quality  of  the  corneal
ront  surface  and  so  to  a  better  image  optical  quality,  as
bserved  in  other  studies.35 In  our  study,  we  have  achieved
he  goal  of  reducing  as  much  as  possible  the  high  astig-
atism  that  was  present  in  our  post-PKP  eyes  to  obtain  a
etter  visual  acuity  and  a  smoother  corneal  surface.  The
DVA  and  CDVA  improved  without  regression  during  the
2-month  postoperative  follow-up,  which  shows  acceptable
evels  of  predictability,  efﬁciency  and  stability  of  treat-
ent.  The  correction  with  spectacles  after  the  treatment
ed  to  a binocular  vision  greatly  appreciated  by  the  patients
nd  inducing  a  beneﬁt  in  their  daily  life  activities.  Our
esults  should  be  conﬁrmed  in  further  studies  with  longer
ollow-up  periods  and  larger  samples  in  order  to  deﬁne  the
ustomized  PRK  as  a  primary  treatment  strategy  to  correct
table  ametropia  after  PKP.onﬂicts of  interest
he  authors  have  no  conﬂicts  of  interest  to  declare.
PRK  after  PKP  
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